Evidence map›Paper›PMID 35027041›Full record

ArticleBMC palliative care2022

National strategy for palliative care of severely ill and dying people and their relatives in pandemics (PallPan) in Germany - study protocol of a mixed-methods project.

C Bausewein, F Hodiamont, N Berges, A Ullrich, C Gerlach, K Oechsle, B Pauli, J Weber, S Stiel, N Schneider and 36 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC palliative care, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

46 authors.

C BauseweinDepartment of Palliative Medicine, Ludwig-Maximilians-University Munich, Munich University Hospital, Munich, Germany. Claudia.bausewein@med.uni-muenchen.de.ORCID http://orcid.org/0000-0002-0958-3041
F HodiamontDepartment of Palliative Medicine, Ludwig-Maximilians-University Munich, Munich University Hospital, Munich, Germany.
N BergesDepartment of Palliative Medicine, Ludwig-Maximilians-University Munich, Munich University Hospital, Munich, Germany.
A UllrichPalliative Care Unit, Department of Oncology, Hematology and Bone Marrow Transplant, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
C GerlachPalliative Care Unit, Department of Oncology, Hematology and Bone Marrow Transplant, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
K OechslePalliative Care Unit, Department of Oncology, Hematology and Bone Marrow Transplant, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
B PauliDepartment of Palliative Medicine, University of Cologne, Faculty of Medicine and University Hospital, Cologne, Germany.
J WeberHannover Medical School, Institute for General Practice and Palliative Medicine, Palliative Care Reserch Grouph Group, Hannover, Germany.
S StielHannover Medical School, Institute for General Practice and Palliative Medicine, Palliative Care Reserch Grouph Group, Hannover, Germany.
N SchneiderHannover Medical School, Institute for General Practice and Palliative Medicine, Palliative Care Reserch Grouph Group, Hannover, Germany.
N KrummDepartment of Palliative Medicine, University Hospital Aachen, Aachen, Germany.
R RolkeDepartment of Palliative Medicine, University Hospital Aachen, Aachen, Germany.
C GebelDepartment of Palliative Medicine, Jena University Hospital, Jena, Germany.
M JanskyDepartment for Palliative Medicine, Georg August University Goettingen, University Medical Center, Goettingen, Germany.
F NauckDepartment for Palliative Medicine, Georg August University Goettingen, University Medical Center, Goettingen, Germany.
U WeddingDepartment of Palliative Medicine, Jena University Hospital, Jena, Germany.
B van OorschotInterdisciplinary Centre for Palliative Medicine, University Wuerzburg, University Hospital, Wuerzburg, Germany.
C RochInterdisciplinary Centre for Palliative Medicine, University Wuerzburg, University Hospital, Wuerzburg, Germany.
L WernerInterdisciplinary Centre for Palliative Medicine, University Wuerzburg, University Hospital, Wuerzburg, Germany.
M FischerInterdisciplinary Centre for Palliative Medicine, University Wuerzburg, University Hospital, Wuerzburg, Germany.
M SchallenburgerInterdisciplinary Centre for Palliative Care, Heinrich Heine University Duesseldorf, University Hospital, Duesseldorf, Germany.
M C ReutersInterdisciplinary Centre for Palliative Care, Heinrich Heine University Duesseldorf, University Hospital, Duesseldorf, Germany.
J SchwartzInterdisciplinary Centre for Palliative Care, Heinrich Heine University Duesseldorf, University Hospital, Duesseldorf, Germany.
M NeukirchenInterdisciplinary Centre for Palliative Care, Heinrich Heine University Duesseldorf, University Hospital, Duesseldorf, Germany.
A GülayDepartment of Palliative Medicine, University Hospital Bonn, Bonn, Germany.
K MausDepartment of Palliative Medicine, University Hospital Bonn, Bonn, Germany.
B JaspersDepartment of Palliative Medicine, University Hospital Bonn, Bonn, Germany.
L RadbruchDepartment of Palliative Medicine, University Hospital Bonn, Bonn, Germany.
M HeckelDepartment of Palliative Medicine, Comprehensive Cancer Center, CCC Erlangen - EMN, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), University Hospital Erlangen, Erlangen, Germany.
I KlingerDepartment of Palliative Medicine, Comprehensive Cancer Center, CCC Erlangen - EMN, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), University Hospital Erlangen, Erlangen, Germany.
C OstgatheDepartment of Palliative Medicine, Comprehensive Cancer Center, CCC Erlangen - EMN, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), University Hospital Erlangen, Erlangen, Germany.
U KriesenDepartment of Medicine, Clinic III-Hematology, Oncology, Palliative Medicine - CCC Mecklenburg-Vorpommern, Rostock University Medical Center, Rostock, Germany.
C JunghanßDepartment of Medicine, Clinic III-Hematology, Oncology, Palliative Medicine - CCC Mecklenburg-Vorpommern, Rostock University Medical Center, Rostock, Germany.
E LehmannDepartment of Palliative Medicine, Ludwig-Maximilians-University Munich, Munich University Hospital, Munich, Germany.
D GesellDepartment of Palliative Medicine, Ludwig-Maximilians-University Munich, Munich University Hospital, Munich, Germany.
S GauderDepartment of Palliative Medicine, Ludwig-Maximilians-University Munich, Munich University Hospital, Munich, Germany.
C BoehlkeFaculty of Medicine, Medical Center, Department of Palliative Medicine, University of Freiburg, Freiburg, Germany.
G BeckerFaculty of Medicine, Medical Center, Department of Palliative Medicine, University of Freiburg, Freiburg, Germany.
A PralongDepartment of Palliative Medicine, University of Cologne, Faculty of Medicine and University Hospital, Cologne, Germany.
J StruppDepartment of Palliative Medicine, University of Cologne, Faculty of Medicine and University Hospital, Cologne, Germany.
C LeisseFaculty of Medicine and University Hospital, Department I of Internal Medicine, University of Cologne, Cologne, Germany.
K SchloesserDepartment of Palliative Medicine, University of Cologne, Faculty of Medicine and University Hospital, Cologne, Germany.
R VoltzDepartment of Palliative Medicine, University of Cologne, Faculty of Medicine and University Hospital, Cologne, Germany.
N JungFaculty of Medicine and University Hospital, Department I of Internal Medicine, University of Cologne, Cologne, Germany.
S T SimonDepartment of Palliative Medicine, University of Cologne, Faculty of Medicine and University Hospital, Cologne, Germany.
PallPan Study Group

Funding

German Ministry for Education and Research Förderkennzeichen 01KX2021
6 · The paper itself

Abstract

backgroundIn the SARS-CoV-2 pandemic, general and specialist Palliative Care (PC) plays an essential role in health care, contributing to symptom control, psycho-social support, and providing support in complex decision making. Numbers of COVID-19 related deaths have recently increased demanding more palliative care input. Also, the pandemic impacts on palliative care for non-COVID-19 patients. Strategies on the care for seriously ill and dying people in pandemic times are lacking. Therefore, the program 'Palliative care in Pandemics' (PallPan) aims to develop and consent a national pandemic plan for the care of seriously ill and dying adults and their informal carers in pandemics including (a) guidance for generalist and specialist palliative care of patients with and without SARS-CoV-2 infections on the micro, meso and macro level, (b) collection and development of information material for an online platform, and (c) identification of variables and research questions on palliative care in pandemics for the national pandemic cohort network (NAPKON).

methodsMixed-methods project including ten work packages conducting (online) surveys and qualitative interviews to explore and describe i) experiences and burden of patients (with/without SARS-CoV-2 infection) and their relatives, ii) experiences, challenges and potential solutions of health care professionals, stakeholders and decision makers during the SARS-CoV-2 pandemic. The work package results inform the development of a consensus-based guidance. In addition, best practice examples and relevant literature will be collected and variables for data collection identified. DISCUSSION: For a future "pandemic preparedness" national and international recommendations and concepts for the care of severely ill and dying people are necessary considering both generalist and specialist palliative care in the home care and inpatient setting.

Indexed as

COVID-19PandemicsAdultGermanyHumansPalliative CareSARS-CoV-2End of life carePalliative carePandemicPandemic preparednessSARS-CoV-2

Identifiers

PMID35027041
PMCPMC8756412

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.